Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued ...

Patent estate covering atrioventricular interval modulation (“AVIM”) therapy includes 37 issued U.S. patents and 73 patents outside the U.S. that collectively comprise over 1,800 claims related to the treatment of

Related Keywords

United States ,Japan ,New York ,China ,American ,David Hochman ,Sirolimus Angioinfusion ,Kelsey Kirk Ellis ,Bob Yedid ,Company Form ,Linkedin ,Nasdaq ,Orchestra Biomed Holdings Inc ,American Heart Association ,American College Of Cardiology Heart Association ,Medtronic ,Biomed Holdings ,Orchestra Biomed ,Cardiac Neuromodulation Therapy ,High Blood Pressure ,American College ,Backbeat Cardiac Neuromodulation Therapy ,Social Media ,Heart Disease ,Stroke Statistics ,American Heart ,Region ,